H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Motus GI Holdings to $2.50 from $10 and keeps a Buy rating on the shares. The price target is derived from an estimated market value of the company at $50M, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MOTS:
- Motus GI Holdings showcases Pure-Vu Gen 4 Gastro, Colon System at IECED
- Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center
- Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
- Motus GI Announces $3.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
- Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission